CN112690457A - Nutrient composition formula for overweight and obese people - Google Patents

Nutrient composition formula for overweight and obese people Download PDF

Info

Publication number
CN112690457A
CN112690457A CN202011544653.8A CN202011544653A CN112690457A CN 112690457 A CN112690457 A CN 112690457A CN 202011544653 A CN202011544653 A CN 202011544653A CN 112690457 A CN112690457 A CN 112690457A
Authority
CN
China
Prior art keywords
vitamin
overweight
powder
nutrient composition
obese people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011544653.8A
Other languages
Chinese (zh)
Inventor
王景娜
韩蓓
张瑞国
武运浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSPC Zhongnuo Pharmaceutical Taizhou Co Ltd
Original Assignee
CSPC Zhongnuo Pharmaceutical Taizhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSPC Zhongnuo Pharmaceutical Taizhou Co Ltd filed Critical CSPC Zhongnuo Pharmaceutical Taizhou Co Ltd
Priority to CN202011544653.8A priority Critical patent/CN112690457A/en
Publication of CN112690457A publication Critical patent/CN112690457A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01—Instant products; Powders; Flakes; Granules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • A23L19/105—Sweet potatoes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a nutrient composition formula for overweight and obese people, and belongs to the technical field of nutrient supplement. Wherein a nutrient composition formulation for overweight and obese people comprises: 160-800 mu g of vitamin A, 35-15 mu g of vitamin D, 14-100 mg of vitamin E, 225-100 mu g of vitamin K, 2-5 mg of beta-carotene, 100-500 mg of vitamin C, 61.5-10 mg of vitamin B, 122-10 mu g of vitamin B, 200-500 mu g of folic acid, 20-120 mg of fruit and vegetable powder, 0.3-16 mg of lubricant and 250-820 mg of flavoring agent; the invention aims at solving the problem of vitamins which are lacked by overweight and obese people, can enhance satiety of the overweight and obese people by adding the fruit and vegetable powder rich in fiber, quickens intestinal peristalsis, is beneficial to preventing weight gain, solves the problem of fat-soluble vitamin deficiency caused by self diet of the overweight and obese people or by inhibiting fat absorption while taking orlistat and the like, and prevents diabetes, cardiovascular and cerebrovascular diseases and other concomitant diseases caused by metabolic abnormality of homocysteine caused by nutrient deficiency of the overweight and obese patients.

Description

Nutrient composition formula for overweight and obese people
Technical Field
The invention belongs to the technical field of nutrient supplement, and particularly relates to a nutrient composition formula for overweight and obese people.
Background
Obesity is currently in a worldwide epidemic trend, is an independent disease, is a risk factor of type 2 diabetes, cardiovascular disease, hypertension, cerebral apoplexy (stroke) and various cancers, and is listed as one of ten risk factors causing disease burden by the world health organization. At present, the overweight people reach 22.4 percent in China, the obese people are 3.01 percent, so the prevention and control of obesity becomes an irreparable task, in 6 months in 2000, Chinese obesity problem workshop is held by Chinese offices of the International society of Life sciences, clinical medicine, preventive medicine and other multidisciplinary experts are invited, deep discussion and wide communication are carried out on the problems of the epidemic trend of obesity, the relationship between obesity and diseases, the prevention and control measures and the like at home and abroad, the BMI value of 24 is agreed to be the overweight limit of adults in China, and the BMI of 28 is the overweight limit; the waist circumference of the male is more than or equal to 85 cm, and the waist circumference of the female is more than or equal to 80 cm, which is the limit of abdominal fat accumulation; the Chinese medical society clinical application of vitamin mineral supplement in preventing and treating overweight and obesity: expert consensus states that "overweight and obese patients are often associated with multiple vitamin deficiencies: the serum vitamin E concentration of the adult obese patients without diabetes and hypertension is obviously reduced compared with the adult obese patients with normal weight; obese subjects have significantly lower serum levels of beta-carotene than normal body weight subjects; the vitamins B6 and C of the obese people are obviously reduced compared with the normal weight people; morbidly obese patients (BMI >40 kg/m 2) are often accompanied by vitamin D deficiency; obese patients are at a 4.3-fold higher risk of vitamin B12 deficiency than normal; clinical studies of vitamins and the development and progression of overweight and obesity: vitamin C content and body fat content are in a negative correlation, and when a person takes sufficient vitamin C, the oxidation of fat in moderate exercise can be increased by 30% compared with low-level vitamin C.
In the consensus of Chinese overweight/obesity medical nutrition therapists (2016 edition), it was noted that "obesity is associated with metabolic abnormalities in certain micronutrients, especially deficiencies in calcium, iron, zinc, vitamin A, vitamin D and folic acid".
The American academy of endocrine Commission "guidelines for the prevention and treatment of vitamin D deficiency" states that obese children and adults require at least 2 or 3 times the amount of vitamin D in the same age group to maintain the body's vitamin D requirement ".
Similar products such as multi-vitamin mineral tablets or multi-vitamin tablets in the current market are suitable for people positioned in all people lacking nutrients, and are not suitable for refining of people, however, the nutrients lacking in different stages of each people are different, especially, the degree of the nutrient deficiency of overweight and obese people is more serious than that of people with normal body weight, and the problem of more serious nutrient deficiency is brought by taking weight-reducing medicines, so that the development of a nutrient composition for the overweight and obese people is urgently needed, and the problem of fat-soluble vitamin deficiency caused by the fact that fat absorption is inhibited by taking orlistat and the like is particularly solved; however, in the current market, a nutrient formula for overweight and obese people is not needed, and in addition, the disease control department of the Ministry of health of China, "Chinese guidelines for prevention and control of overweight and obesity for adults (trial implementation), clearly indicates that obesity is an independent disease, is a risk factor of various diseases such as type 2 diabetes mellitus, cardiovascular diseases and the like, and is listed as one of ten risk factors causing disease burden by the world health organization, so the prevention of the accompanying diseases is particularly important.
Disclosure of Invention
The purpose of the invention is as follows: a nutrient composition formulation for overweight and obese people is provided to solve the above problems of the prior art.
The technical scheme is as follows: a nutrient composition formula for overweight and obese people is characterized by comprising the following components in percentage by daily weight of the nutrient: 160-800 mu g of vitamin A, 35-15 mu g of vitamin D, 14-100 mg of vitamin E, 225-100 mu g of vitamin K, 2-5 mg of beta-carotene, 100-500 mg of vitamin C, 61.5-10 mg of vitamin B, 122-10 mu g of vitamin B, 200-500 mu g of folic acid, 20-120 mg of fruit and vegetable powder, 0.3-16 mg of lubricant and 250-820 mg of flavoring agent.
In further embodiments, the vitamin a is one or both of vitamin a acetate, retinyl palmitate, and beta-carotene.
In a further embodiment, the vitamin E is one or more of D-alpha-tocopherol, D-alpha-tocopherol acetate, D-alpha-tocopherol succinate, dl-alpha-tocopherol acetate, dl-alpha-tocopherol, and calcium vitamin E succinate.
In a further embodiment, the beta-carotene is a beta-carotene embedding powder.
In a further embodiment, the vitamin C is one or more of L-ascorbic acid, sodium L-ascorbate, calcium L-ascorbate and ascorbyl palmitate.
In a further embodiment, the fruit and vegetable powder is one of dragon fruit powder, purple sweet potato powder, tomato powder, blueberry powder and strawberry powder.
In a further embodiment, the lubricant is one of magnesium stearate, talc, aerosil.
In a further embodiment, the flavoring agent is one or more of essence, spice, aspartame, sucralose, stevioside, saccharin sodium, sorbitol and xylitol; the essence is one or more of dragon fruit essence, purple sweet potato essence and yoghourt series essence.
In further embodiments, the nutrient composition can be made into various forms including buccal tablets, chewable tablets, granules, hard capsules, soft capsules, powders, pills, oral liquids, syrups.
In a further embodiment, the nutrient composition contains fat soluble vitamins including: vitamin a, vitamin D3, vitamin E, vitamin K2, and beta-carotene; contains water soluble vitamins including vitamin C, vitamin B6, folic acid, and vitamin B12.
Has the advantages that: the invention develops a nutrient composition formula aiming at the problem of nutrient deficiency of overweight and obese people, wherein fat-soluble vitamin A, vitamin D3, vitamin E, vitamin K2, beta-carotene, water-soluble vitamin C, vitamin B6, folic acid and vitamin B12 are easy to be deficient for the overweight and obese people, the vitamins B6, B12 and folic acid are essential nutrients for maintaining normal metabolism of homocysteine, the addition of fruit and vegetable powder is more beneficial to solving the problems of constipation and the like of weight-losing people, and the components in the formula all accord with the corresponding national standard.
The nutrient composition has the advantages that (1) the vitamins which are lacked by overweight and obese people are pertinently solved, the satiety of the overweight and obese people can be enhanced by adding the fruit and vegetable powder rich in fiber, the intestinal peristalsis is accelerated, and the weight gain is more favorably prevented; (2) the problem of fat-soluble vitamin deficiency caused by self diet of overweight and obese people or caused by inhibiting fat absorption while taking orlistat and the like is solved; (3) preventing the metabolic abnormality of homocysteine caused by nutrient deficiency of overweight and obese patients from causing the concomitant diseases such as diabetes, cardiovascular and cerebrovascular diseases and the like.
Drawings
Figure 1 is a table of the nutrient composition formulations of the present invention.
Detailed Description
In the following description, numerous specific details are set forth in order to provide a more thorough understanding of the present invention. It will be apparent, however, to one skilled in the art, that the present invention may be practiced without one or more of these specific details. In other instances, well-known features have not been described in order to avoid obscuring the invention.
The invention is further described in detail below:
the present invention provides a nutrient composition formulation for overweight and obese people, comprising: 160-800 mu g of vitamin A (calculated by retinol RE), 5-15 mu g of vitamin D3 (calculated by cholecalciferol), 14-100 mg of vitamin E (calculated by D-alpha-tocopherol), 25-100 mu g of vitamin K2 (calculated by heptaene menadione), 2-5 mg of beta-carotene, 100-500 mg of vitamin C (calculated by L-ascorbic acid), 1.5-10 mg of vitamin B6 (calculated by pyridoxine), 2-10 mu g of vitamin B12 (calculated by cobalamin), 200-500 mu g of folic acid (calculated by folic acid), 20-120 mg of fruit and vegetable powder, 0.3-16 mg of lubricant and 250-820 mg of flavoring agent, and then the mixture is prepared into dosage forms with different specifications through a granulation or direct tabletting process.
The vitamin A is one or two of vitamin A acetate, retinyl palmitate and beta-carotene, the vitamin A acetate is one or more of D-alpha-tocopherol, D-alpha-tocopherol acetate, D-alpha-tocopherol succinate, dl-alpha-tocopherol acetate, dl-alpha-tocopherol and calcium vitamin E succinate, the beta-carotene is beta-carotene embedded powder, the vitamin C is one or more of L-ascorbic acid, L-sodium ascorbate, L-calcium ascorbate and ascorbyl palmitate, the fruit and vegetable powder is one or more of dragon fruit powder, purple sweet potato powder, tomato powder, blueberry powder and strawberry powder, and the lubricant is magnesium stearate, calcium palmitate, and the lubricant is magnesium stearate, One or more of essence, spice, aspartame, sucralose, stevioside, saccharin sodium, sorbitol and xylitol is used as the flavoring agent, one or more of dragon fruit essence, purple sweet potato essence and yoghourt series essence is used as the essence, the nutrient composition can be prepared into various states, including buccal tablets, chewable tablets, granules, hard capsules, soft capsules, powder, pills, oral liquid and syrup, the nutrient composition is mainly used for supplementing nutrients for overweight and obese people and preventing related diseases caused by fat deficiency caused by reduction of human fat absorption caused by use of orlistat or other weight-reducing medicines, and the vitamin K2 can prevent calcium from depositing in arteries so as to prevent related diseases such as arteriosclerosis, coronary heart disease and the like, the vitamin B6, the vitamin B12 and the folic acid are nutrients which are necessary for maintaining normal metabolism of homocysteine, are beneficial to maintaining normal metabolism of human homocysteine, and can prevent diabetes, cardiovascular and cerebrovascular diseases and other related diseases of overweight and obese patients caused by the increase of homocysteine due to vitamin deficiency.
The fruit and vegetable powder is more beneficial to solving the problems of constipation and the like of weight-losing people, the intake of dietary fiber in vivo is increased, satiety can be increased, intestinal peristalsis can be enhanced, the discharge of toxin in vivo can be accelerated, overweight and obesity can be prevented, the components in the formula accord with the corresponding national standards, the fruit and vegetable powder is mainly used for nutrient supplement of overweight and obesity people and prevention of associated diseases thereof, and simultaneously can be used for prevention of related diseases caused by fat-soluble vitamin deficiency caused by reduction of human fat absorption caused by the use of orlistat or other weight-losing medicines.
The invention has the advantages that: (1) the vitamins which are lacked by overweight and obese people are pertinently solved, and the satiety of the overweight and obese people can be enhanced by adding the fruit and vegetable powder rich in fiber, so that the intestinal peristalsis is accelerated, and the weight gain is more favorably prevented; (2) the problem of fat-soluble vitamin deficiency caused by self diet of overweight and obese people or caused by inhibiting fat absorption while taking orlistat and the like is solved; (3) preventing the metabolic abnormality of homocysteine caused by nutrient deficiency of overweight and obese patients from causing the concomitant diseases such as diabetes, cardiovascular and cerebrovascular diseases and the like.
Example 1
The daily dose is 2 tablets, each tablet is prepared from 1.79mg of vitamin A acetate (325000 IU), 2mg of vitamin D3 powder (100000 IU), 30mg of D-alpha-tocopherol (mass fraction is 50%), 6.5mg of vitamin K2 powder (2000 ppm), 15mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B61.85mg, 0.3mg of vitamin B12 powder (mass fraction is 1%), 2mg of folic acid (mass fraction is 10%), 100mg of L-ascorbic acid, 380.06mg of sorbitol, 1.8mg of aspartame, 0.6mg of magnesium stearate, 0.6mg of dragon fruit essence and 60mg of dragon fruit powder through granulation, mixing and tabletting processes to prepare the buccal tablet with the tablet weight of 0.60 g.
Example 2
The daily dose is 1 tablet, each tablet is prepared from 3.58mg of vitamin A acetate (325000 IU), 4mg of vitamin D3 powder (100000 IU), 50mg of D-alpha-tocopherol (mass fraction is 50%), 12.5mg of vitamin K2 powder (2000 ppm), 30mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B63.65mg, 0.6mg of vitamin B12 powder (mass fraction is 1%), 4mg of folic acid (mass fraction is 10%), 200mg of L-ascorbic acid, 424.39mg of sorbitol, 1.98mg of aspartame, 7.9mg of magnesium stearate, 7.9mg of dragon fruit essence and 39.5mg of dragon fruit powder through granulation, mixing and tabletting processes to prepare the buccal tablet with the tablet weight of 0.79 g.
Example 3
The daily dose is 1 tablet, each tablet is prepared from 3.58mg of vitamin A acetate (325000 IU), 4mg of vitamin D3 powder (100000 IU), 50mg of D-alpha-tocopherol (mass fraction is 50%), 12.5mg of vitamin K2 powder (2000 ppm), 30mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B63.65mg, 0.6mg of vitamin B12 powder (mass fraction is 1%), 4mg of folic acid (mass fraction is 10%), 200mg of L-ascorbic acid and 800mg of sorbitol; aspartame 3 mg; 12mg of magnesium stearate; 12mg of dragon fruit essence; 70mg of dragon fruit powder is prepared into the buccal tablet with the tablet weight of 1.20g by granulation and mixed tabletting process.
Example 4
The daily dose is 2 tablets, each tablet is prepared from 1.79mg of vitamin A acetate (325000 IU), 2mg of vitamin D3 powder (100000 IU), 30mg of D-alpha-tocopherol (mass fraction is 50%), 6.5mg of vitamin K2 powder (2000 ppm), 15mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B61.85mg, 0.3mg of vitamin B12 powder (mass fraction is 1%), 2mg of folic acid (mass fraction is 10%), 100mg of L-ascorbic acid, 380.06mg of sorbitol, 1.8mg of aspartame, 0.6mg of magnesium stearate, 0.6mg of dragon fruit essence and 60mg of dragon fruit powder through a direct mixing and tabletting process, and the chewable tablet is 0.60 g.
Example 5
The daily dose is 1 tablet, each tablet is prepared from 3.58mg of vitamin A acetate (325000 IU), 4mg of vitamin D3 powder (100000 IU), 50mg of D-alpha-tocopherol (mass fraction is 50%), 12.5mg of vitamin K2 powder (2000 ppm), 30mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B63.65mg, 0.6mg of vitamin B12 powder (mass fraction is 1%), 4mg of folic acid (mass fraction is 10%), 200mg of L-ascorbic acid, 424.39mg of sorbitol, 1.98mg of aspartame, 7.9mg of magnesium stearate, 7.9mg of dragon fruit essence and 39.5mg of dragon fruit powder through a direct mixing and tabletting process, and the chewable tablet with the weight of 0.79g is prepared.
Example 6
The daily dose is 1 tablet, each tablet is prepared from 3.58mg of vitamin A acetate (325000 IU), 4mg of vitamin D3 powder (100000 IU), 50mg of D-alpha-tocopherol (mass fraction is 50%), 12.5mg of vitamin K2 powder (2000 ppm), 30mg of beta-carotene embedding powder (mass fraction is 10%), vitamin B63.65mg, 0.6mg of vitamin B12 powder (mass fraction is 1%), 4mg of folic acid (mass fraction is 10%), 200mg of L-ascorbic acid and 800mg of sorbitol; aspartame 3 mg; 12mg of magnesium stearate; 12mg of purple sweet potato essence; 70mg of purple sweet potato powder is prepared into chewable tablets with the tablet weight of 1.20g by a direct mixing and tabletting process.
The above is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and those skilled in the art can make various equivalent changes to the technical solution of the present invention within the technical idea of the present invention, and these equivalent changes are all within the protection scope of the present invention.

Claims (10)

1. A nutrient composition formula for overweight and obese people is characterized by comprising the following components in percentage by daily weight of the nutrient: 160-800 mu g of vitamin A, 35-15 mu g of vitamin D, 14-100 mg of vitamin E, 225-100 mu g of vitamin K, 2-5 mg of beta-carotene, 100-500 mg of vitamin C, 61.5-10 mg of vitamin B, 122-10 mu g of vitamin B, 200-500 mu g of folic acid, 20-120 mg of fruit and vegetable powder, 0.3-16 mg of lubricant and 250-820 mg of flavoring agent.
2. The nutritional composition formulation according to claim 1, wherein the vitamin A is one or both of vitamin A acetate, retinyl palmitate and beta-carotene.
3. A nutrient composition formulation for overweight and obese people according to claim 1, wherein the vitamin E is one or more of D-alpha-tocopherol, D-alpha-tocopherol acetate, D-alpha-tocopherol succinate, dl-alpha-tocopherol acetate, dl-alpha-tocopherol, calcium vitamin E succinate.
4. A nutrient composition formulation for overweight and obese people, according to claim 1, wherein the beta-carotene is a beta-carotene embedded powder.
5. The nutrient composition formula for overweight and obese people according to claim 1, wherein the vitamin C is one or more of L-ascorbic acid, sodium L-ascorbate, calcium L-ascorbate, ascorbyl palmitate.
6. The nutrient composition formula for overweight and obese people according to claim 1, wherein the fruit and vegetable powder is one of dragon fruit powder, purple sweet potato powder, tomato powder, blueberry powder, strawberry powder.
7. The nutritional composition formulation according to claim 1, wherein the lubricant is one of magnesium stearate, talc, and aerosil.
8. The nutrient composition formula for overweight and obese people according to claim 1, wherein the flavoring agent is one or more of essence, spice, aspartame, sucralose, stevioside, saccharin sodium, sorbitol, xylitol; the essence is one or more of dragon fruit essence, purple sweet potato essence and yoghourt series essence.
9. The nutrient composition formulation of claim 1, wherein the nutrient composition is formulated in a variety of forms including lozenges, chewable tablets, granules, hard capsules, soft capsules, powders, pills, oral liquids, syrups.
10. The nutrient composition formulation according to claim 1, wherein the nutrient composition contains fat-soluble vitamins comprising: vitamin a, vitamin D3, vitamin E, vitamin K2, and beta-carotene; contains water soluble vitamins including vitamin C, vitamin B6, folic acid, and vitamin B12.
CN202011544653.8A 2020-12-24 2020-12-24 Nutrient composition formula for overweight and obese people Pending CN112690457A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011544653.8A CN112690457A (en) 2020-12-24 2020-12-24 Nutrient composition formula for overweight and obese people

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011544653.8A CN112690457A (en) 2020-12-24 2020-12-24 Nutrient composition formula for overweight and obese people

Publications (1)

Publication Number Publication Date
CN112690457A true CN112690457A (en) 2021-04-23

Family

ID=75509512

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011544653.8A Pending CN112690457A (en) 2020-12-24 2020-12-24 Nutrient composition formula for overweight and obese people

Country Status (1)

Country Link
CN (1) CN112690457A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114128894A (en) * 2021-05-26 2022-03-04 石药集团中诺药业（泰州）有限公司 Uric acid reducing nutrient composition for people with high uric acid and gout and preparation method thereof
CN116784479A (en) * 2023-05-08 2023-09-22 石药集团中诺药业（泰州）有限公司 Homocysteine-reducing B-vitamin tablet

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683477A (en) * 2008-09-25 2010-03-31 凌沛学 Composition for fat-reducing
CN103735556A (en) * 2013-11-21 2014-04-23 荣成百合生物技术有限公司 Multivitamin mineral composite effervescent tablet and preparation method thereof
CN107648313A (en) * 2017-11-08 2018-02-02 罗昌兴 A kind of Western medicine compound for treating obesity and preparation method thereof
CN107712907A (en) * 2017-09-18 2018-02-23 诺和生物技术（天津）有限公司 Composition that a kind of suitable fat and fat reducing operation crowd eats and preparation method thereof
CN111011691A (en) * 2019-12-05 2020-04-17 陕西中鸿科瑞再生医学研究院有限公司 High-protein high-fiber solid beverage
CN111328949A (en) * 2018-12-19 2020-06-26 浙江唯娜科技有限公司 B-vitamin composition solid beverage

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683477A (en) * 2008-09-25 2010-03-31 凌沛学 Composition for fat-reducing
CN103735556A (en) * 2013-11-21 2014-04-23 荣成百合生物技术有限公司 Multivitamin mineral composite effervescent tablet and preparation method thereof
CN107712907A (en) * 2017-09-18 2018-02-23 诺和生物技术（天津）有限公司 Composition that a kind of suitable fat and fat reducing operation crowd eats and preparation method thereof
CN107648313A (en) * 2017-11-08 2018-02-02 罗昌兴 A kind of Western medicine compound for treating obesity and preparation method thereof
CN111328949A (en) * 2018-12-19 2020-06-26 浙江唯娜科技有限公司 B-vitamin composition solid beverage
CN111011691A (en) * 2019-12-05 2020-04-17 陕西中鸿科瑞再生医学研究院有限公司 High-protein high-fiber solid beverage

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114128894A (en) * 2021-05-26 2022-03-04 石药集团中诺药业（泰州）有限公司 Uric acid reducing nutrient composition for people with high uric acid and gout and preparation method thereof
CN116784479A (en) * 2023-05-08 2023-09-22 石药集团中诺药业（泰州）有限公司 Homocysteine-reducing B-vitamin tablet

Similar Documents

Publication Publication Date Title
US5364644A (en) Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
KR101573316B1 (en) Multi-vitamin and mineral nutritional supplements
US20040082536A1 (en) Multi-vitamin and mineral supplement
US6562378B1 (en) Nutritional supplement for adolescents
US20240122966A1 (en) Enhanced nitrate compositions and methods of use
CN112690457A (en) Nutrient composition formula for overweight and obese people
US20120294983A1 (en) Nutritional Formulation
EP2385769A1 (en) Rapidly dissolving vitamin formulation and methods of using the same
CN101366871B (en) Medicament composition for preventing birth defect and improving memory
WO2014016627A1 (en) Vitamin and mineral preparations for gravidae for use in trimesters of pregnancy
US7998500B2 (en) Nutritional supplement for women
CN1281216C (en) Instant nutrition intensifying agent
Dickerson Some adverse effects of drugs on nutrition
CN101366867B (en) Medicament composition for preventing birth defect and improving memory
CN101366778B (en) Medicament composition for preventing birth defection and improving memory
CN1194711C (en) Medicine 'Xuewang' for treating anemia
CN113142563A (en) Predigested total-nutrient formula food containing soluble dietary fibers
CN101396501A (en) Medicine composition for preventing the birth defect and improving the memory
CN101601683A (en) The pharmaceutical composition that is used for blood sugar lowering and blood fat and treatment diabetes
CN101474300A (en) Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes
CN101371863A (en) Pharmaceutical combination for preventing birth-defect and improving memory
CN101366758A (en) Pharmaceutical combination for preventing birth defect and improving anamnesis
CN101396503A (en) Medicine composition for preventing the birth defect and improving the memory
MXPA06011027A (en) Multi-vitamin and mineral nutritional supplements
CN101396502A (en) Medicine composition for preventing the birth defect and improving the memory

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210423